Beta1-integrins control spontaneous adhesion and motility of human progenitor thymocytes and regulate differentiation-dependent expression of the receptor for hyaluronan-mediated motility

Scandinavian Journal of Immunology

Volumn 50, Issue 6, 1999, Pages 626-634

  Gares, S L ^b   Pilarski, Linda M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FIBRONECTIN; HYALURONIC ACID; INTEGRIN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; BETA1 INTEGRIN; FIBRONECTIN RECEPTOR; HERMES ANTIGEN; HOMING RECEPTOR; HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONAN-MEDIATED MOTILITY RECEPTOR; MESSENGER RNA; SCLEROPROTEIN; T LYMPHOCYTE ANTIGEN; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; STEM CELL; T LYMPHOCYTE; THYMOCYTE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MOTION; CHILD; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFANT; METABOLISM; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; THYMUS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CHILD; CHILD, PRESCHOOL; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYALURONIC ACID; INFANT; INFANT, NEWBORN; INTEGRIN ALPHA4BETA1; INTEGRINS; RECEPTORS, FIBRONECTIN; RECEPTORS, LYMPHOCYTE HOMING; RNA, MESSENGER; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0033254498     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00638.x     Document Type: Article

References (53)

1. Roushlati E, Yamaguchi Y. Proteoglycans as modulators of growth factor activity. Cell 1991;64:867-9.
2. Gingell D, Owens N. How do cells sense and respond to adhesive contacts? Diffusion-trapping of laterally mobile membrane proteins at maturing adhesions may initiate signals leading to local cytoskeletal assembly response and lamella formation. J Cell Sci 1992;101:25-66.
3. McCarthy J, Turley EA. Effects of extracellular matrix components on cellular locomotion. Crit Rev Oral Biol Med 1993;4:619-37.
4. Stossel TP. How cells crawl. Am Scientist 1990;78:408-23.
5. Hynes RO. Integrins. Versatility modulation and signaling in cell adhesion. Cell 1992;69:11-25.
6. Hangan D, Morris VL, Boeters L, Von Ballestrem C, Uniyal S, Chan BMC. An epitope on VLA-6 (a6b1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. Cancer Res 1997;43:455-68.
7. Ho WC, Heinemann C, Hangan D, Uniyal S, Chan BMC. Modulation of in vivo migratory function of a2b1 integrin in mouse. Mol Biol Cell 1997;8:1863-975.
8. Friedl P, Noble PB, Zanker KS. T lymphocyte locomotion in a three-dimensional collagen matrix. Expression and function of cell adhesion molecules. J Immunol 1995;154:4973-85.
9. Hauzenberger D, Klominek J, Holgersson J, Bergstrom S-E, Sundqvist K-G. Triggering of motile behavior in T lymphocytes via cross-linking of α4β1 andαLβ2. J Immunol 1997;158:76-84.
10. Gates SL, Gianniakopoulos NV, MacNeil D, Faull RJ, Pilarski LM. During human thymocyte differentiation, β1 integrins regulate adhesion, motility and the outcome of RHAMM-hyaluronan engagement. J Leukoc Biol 1998;64:781-90.
11. Salomon DR, Mojcik CF, Chang AC et al. Constitutive activation of alpha4 beta1 defines a unique stage of human thymocyte development. J Exp Med 1994;179:1573-84.
12. Pilarski LM, Miszta H, Turley EA. Regulated expression of a receptor for hyaluronan-mediated motility (RHAMM) on human thymocytes and T cells. J Immunol 1993;150:4292-302.
13. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM, Hyaluronan-dependent motility of B cells and leukemic plasma cells but not of bone marrow plasma cells in multiple myeloma: alternate usage of RHAMM and CD44. Blood 1996;87:1891-9.
14. Crainie M, Mant MJ, Belch AR, Pilarski LM. Overexpression of the hyaluronan receptor RHAMM characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM isoforms. Blood 1999;93:1684-96.
15. Pilarski LM, Pruski F, Wizniak J et al. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Blood 1999;93:2918-27.
16. Hardwick C, Hoare K, Owens R et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor motility. J Cell Biol 1992;117:1343-50.
17. Entwhistle J, Zhang S, Yang B et al. Cloning and characterization of the gene encoding the hyaluronan receptor RHAMM. The role of a secreted isoform in the regulation of focal adhesion formation. Gene 1995;163:233-8.
18. Hall CL, Yang X, Zhang S et al. Overexpression of the hyaluronan receptor RHAMM is transforming, and is required for H-ras transformation. Cell 1995;82:19-28.
19. Turley EA. Hyaluronic acid stimulates protein kinase activity in intact cells and in an isolated protein complex. J Biol Chem 1989;264:8951-5.
20. Turley EA, Austin L, Vandligt K, Clary C. Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 1991;112:1041-7.
21. Turley EA, Bowman P, Kytryk MA. Effects of hyaluronate binding proteins on cell motile and contact behavior. J Cell Sci 1985;78:133-45.
22. Entwhistle J, Hall CL, Turley EA. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996;61:569-77.
23. Hall CL, Wang C, Lange L, Turley EA. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994;126:575-88.
24. Hall CL, Lange LA, Prober DA, Zhang S, Turley EA. pp60 (c-src) is required for cell locomotion regulated by the hyaluronan receptor RHAMM. Oncogene 1996;13:2213-24.
25. Gares SL, Pilarski LM. Balancing thymocyte adhesion and motility: a functional linkage between B1 integrins and the motility receptor RHAMM. Dev Immunol 1999; in press.
26. Pilarski LM. Antigen-independent adhesive interactions in thymic development: implications for cell type specific function. In: Shimizu Y, eds. Lymphocyte Adhesion Molecules. XXXXX: R. G. Landes Co., Austin, Texas 1993: 221-48.
27. Pilarski LM. Adhesive interactions in thymic development. Does selective expression of CD45 isoforms promote stage-specific microclustering in the assembly of functional adhesive complexes on differentiating T lymphocytes? Immunol Cell Biol 1992;71:59-69.
28. Pilarski LM, Deans JP. CD45 isoform transitions on multinegative human thymocytes differentiating in vitro mimic patterns predicted for selective events in vivo. Immunol Cell Biol 1993;71:289-301.
29. -) thymocyte proliferation by monoclonal antibodies to CD45RA or to CD45. Immunol Cell Biol 1994;72:292-9.
30. Deans JP, Wilkins JA, Caixia S, Pruski E, Pilarski LM. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro. J Immunol 1991;147:4060-8.
31. Bergsagel PL, Masellis S, Szczepek A, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56 and monotypic immunoglobulin light chain. Blood 1995;85:436-447.
32. Wilkins JA, Stupack D, Stewart S, Shen C. β1 integrin-mediated lymphocyte adherence to extracellular matrix is enhanced by phorbol ester treatment. Eur J Immunol 1991;21:517-22.
33. Caixia S, Stewart S, Wayner E, Carter W, Wilkins J. Antibodies to different members of the b1 (CD29) integrins induce homotypic and heterotypic cellular aggregation. Cell Immunol 1991;138:216-28.
34. Jensen GS, Belch AR, Kherani F, Mant MJ, Ruether BA, Pilarski LM. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand J Immunol 1992;36:843-53.
35. Deans JP, Serra HM, Shaw J, Shen YJ, Torres RM, Pilarski LM. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J Immunol 1992;148:1898-905.
36. Turley EA, Belch AR, Poppema S, Pilarski LM. Expression and function of a receptor for hyaluronan-mediated motility (RHAMM) on normal and malignant B lymphocytes. Blood 1993;81:446-53.
37. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990;8:365-400.
38. Pilarski LM, Yacyshyn B, Jensen GS, Pruski EP, Pabst HF. Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression. J Immunol 1991;147:830-7.
39. Pilarski LM, Laderoute MP, Rutkowski D. Apoptosis among CD45RA-/low CD3+ progeny accompanies differentiation of human multinegative thymocytes. Scand J Immunol 1995;41:237-46.
40. Crisa L, Cirulli V, Ellisman MH, Ishii JK, Elices MJ, Salomon DR. Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4 and VLA5. J Exp Med 1996;184:215-28.
41. Fehlner-Gardiner CC, Uniyal S, Von Ballestrem C, Chan BMC. Differential utilization of VLA-4 (α4β1) and -5 (α5β1) integrins during the development of mouse bone marrow-derived mast cells. Differentiation 1996;60:317-25.
42. Chan BMC, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. Cell 1992;68:1051-60.
43. Turley EA, Auersperg N. A hyaluronate binding protein transiently codistributes with p21 k-ras in cultured cell lines. Exp Cell Res 1989;182:340-8.
44. Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res 1985;161:17-28.
45. Pilarski LM, Masellis Smith A, Belch AR, Yang B, Savani RC, Turley EA. RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: a mediator in B cell malignancy? Leuk Lymphoma 1994;14:363-74.
46. Mueller SC, Chen WT. Cellular invasion into matrix beads: localization of beta1 integrins and fibronectin to the invadopodia. J Cell Sci 1991;99:213-25.
47. Mueller SC, Kelly T, Dai M, Dai H, Chen WT. Dynamic cytoskeletal-integrin associations induced by cell binding to immobilized fibronectin. J Cell Biol 1989;109:3455-64.
48. Duband JL, Dufour S, Yamada S, Yamada K, Thiery JP. Neural crest cell locomotion induced by antibodies to beta 1 integrins. A tool for studying the roles of substratum molecular avidity and density in migration. J Cell Sci 1991;98:517-32.
49. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM. Activation of B1 integrins on CML progenitors reveals cooperation between B1 integrin and CD44 in the regulation of adhesion and proliferation. Leukemia 1997;11:822-9.
50. Tanaka Y, Albelda SM, Horgan KJ et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta1 integrin-mediated adhesion. J Exp Med 1992;176:245-53.
51. Koopman G, Van Kooyk Y, De Graaff M, Meyer CLJM, Figdor CG, Pals ST. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol 1990;145:3589-93.
52. Charo IF, Nannizzi L, Smith JW, Cheresh DA. The vitronectin receptor avb3 binds fibronectin and acts in concert with a5b1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1990;111:2795-800.
53. Pilarski LM, Howland KL, Deans JP. Sensitivity and resistance to cyclosporin A among differentiating human multinegative thymocytes. Scand J Immunol 1994;39:363-72.